noscript

News and Announcements

MedAdvisor Signs Strategic Agreement with Arrow Pharmaceuticals

  • Published June 01, 2016 2:46PM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

1st June 2016, ASX Announcement

Highlights:

  • MedAdvisor has  sign a strategic agreement with Arrow Pharmaceuticals, one of Australia’s largest generic pharmaceutical manufacturers
  • Arrows Pharmaceuticals’ 35 plus strong national sales teams to promote the MedAdvisor platform to its extensive first-line customer base of over 1,100 pharmacies from June 2016
  • Strong platform validation with MedAdvisor now partnered with Australia’s two largest generic companies: Apotex and Arrow Pharmaceuticals
  • Aligns with MedAdvisor’s strategy to substantially increase its referrer and patient customer base to drive revenue and growth

MedAdvisor Limied (ASX:MDR, the Company), Australia’s leading digital medication adherence company, is pleased to announce that it has signed  a binding strategic agreement with Arrow Pharmaceuticals, Australia’s second largetst generic pharmaceutical manufactures, following the announcement of its Memorandum of Understanding in March 2016.

To view the full announcement, please click on the button below.

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now